Jared Weiss

8PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 26, 2026
Exploring Clinical Pathways to a Metastatic Lung Cancer Diagnosis: A Latent Class Analysis Using North Carolina Multipayer Claims Data.

Lorinda A Coombs, Xi Zhou, Katherine E Reeder-Hayes

|Feb 05, 2026
Shared PRAME epitopes are T-cell targets in NUT carcinoma.

Jeffrey L Jensen, Sara K Peterson, Maria J Sambade

|Jul 03, 2023
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.

Shetal A Patel, Michael K Gibson, Allison Deal

|Aug 11, 2021
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.

Bhishamjit S Chera, Siddharth H Sheth, Shetal A Patel

|May 06, 2021
Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m2 ?

Jared M Weiss

|Jan 17, 2020
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy.

Jared M Weiss, Nathan Pennell, Allison M Deal

Pageof 2

Frequent Collaborators

3 joint publications

Bhishamjit S Chera

2 joint publications

Siddharth Sheth

2 joint publications

Kathe E Douglas

2 joint publications

Jennifer L Lund